Arterial Vascular Engineering AVEI Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: gbh who wrote (243)	6/23/1998 6:01:00 PM
From: gbh	Read Replies (2) of 410

From Yahoo message board. I don't know about the reliability. messages.yahoo.com@m2.yahoo.com AVEI Management Provides Revenue Guidance for Qtr DustyRoads91 Jun 22 1998 5:01PM EDT I spoke today with stock analyst who called AVEI management late last week. Company provided guidance indicating that quarter will exceed $170 MM and will exceed current market consensus for earnings estimates. Company currently producing at capacity -- which they are shipping immediately. No inventory buildup is occurring. Following formal earnings release, stock analyst expects Goldman and others to INCREASE EPS estimates for Calendar 98 and next Fiscal 99 periods. NIR vs GFX: GS and others have canvassed cath labs and the consensus is that each technology (NIR vs GFX) will acquire an equal market share (approx)in the future; in the face of this information, GS and others believe that AVEI will continue earnings growth into 1999 and beyond. Goldman and Others are perplexed at the market reaction in the face of solid current earnings, opinions of professionals interviewed in cath labs and buyout valuation of AVEI (approx $55.00) Current TA is negative with probable $27.00 before $30.00

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next